Company Overview of APT Pharmaceuticals, Inc.
Key Executives for APT Pharmaceuticals, Inc.
|Howard V. Raff Ph.D.||1 Relationships||Chief Operating Officer||65|
|Susan E. Barrowcliffe BSc||No Relationships||Global Head of Regulatory Affairs and Executive Vice President of Development - Europe||58|
|Joe Melvin||No Relationships||Vice President of Finance and Strategic Planning||--|
|Amy Burroughs Nader||No Relationships||Chief Commercial Officer and Head of Commercial & Business Development||--|
APT Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Fred M. Schwarzer J.D.||21 Relationships||Charter Life Sciences||--|
|Albert Cha M.D., Ph.D., MS||52 Relationships||Vivo Capital, LLC||44|
|David E. Kroin||16 Relationships||Great Point Partners, LLC||41|
|Paul J. Sekhri||199 Relationships||Lycera Corp.||58|
|Nina S. Kjellson||80 Relationships||Canaan Partners||41|
APT Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.